USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 168 filers reported holding USANA HEALTH SCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $211 | +63.6% | 4,500 | +87.1% | 0.01% | -16.7% |
Q4 2023 | $129 | -29.5% | 2,405 | -23.0% | 0.01% | -25.0% |
Q3 2023 | $183 | -8.5% | 3,123 | -1.5% | 0.01% | 0.0% |
Q2 2023 | $200 | -23.1% | 3,172 | -23.3% | 0.01% | -27.3% |
Q1 2023 | $260 | +17.6% | 4,138 | -0.4% | 0.01% | +10.0% |
Q4 2022 | $221 | -99.9% | 4,153 | -17.5% | 0.01% | -9.1% |
Q3 2022 | $282,000 | -38.6% | 5,031 | -20.7% | 0.01% | -21.4% |
Q2 2022 | $459,000 | -8.7% | 6,348 | +0.2% | 0.01% | +16.7% |
Q1 2022 | $503,000 | -31.7% | 6,336 | -12.9% | 0.01% | -20.0% |
Q4 2021 | $736,000 | +10.3% | 7,272 | +0.5% | 0.02% | 0.0% |
Q3 2021 | $667,000 | -13.7% | 7,235 | -4.1% | 0.02% | 0.0% |
Q2 2021 | $773,000 | +57.8% | 7,545 | +50.3% | 0.02% | +50.0% |
Q1 2021 | $490,000 | +26.0% | 5,019 | -0.6% | 0.01% | +25.0% |
Q4 2020 | $389,000 | +4.6% | 5,049 | 0.0% | 0.01% | -11.1% |
Q3 2020 | $372,000 | +0.3% | 5,049 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $371,000 | +25.3% | 5,049 | -1.6% | 0.01% | +12.5% |
Q1 2020 | $296,000 | -27.6% | 5,129 | -1.5% | 0.01% | -11.1% |
Q4 2019 | $409,000 | +11.7% | 5,209 | -2.5% | 0.01% | +12.5% |
Q3 2019 | $366,000 | -14.5% | 5,345 | -0.8% | 0.01% | -11.1% |
Q2 2019 | $428,000 | -7.6% | 5,389 | -2.3% | 0.01% | -10.0% |
Q1 2019 | $463,000 | -28.7% | 5,515 | 0.0% | 0.01% | -37.5% |
Q4 2018 | $649,000 | -10.5% | 5,515 | -8.3% | 0.02% | +14.3% |
Q3 2018 | $725,000 | +4.5% | 6,015 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $694,000 | +27.3% | 6,015 | -5.2% | 0.01% | +27.3% |
Q1 2018 | $545,000 | +16.0% | 6,342 | 0.0% | 0.01% | +22.2% |
Q4 2017 | $470,000 | +28.4% | 6,342 | 0.0% | 0.01% | +12.5% |
Q3 2017 | $366,000 | -12.6% | 6,342 | -3.1% | 0.01% | -11.1% |
Q2 2017 | $419,000 | +11.1% | 6,542 | 0.0% | 0.01% | +12.5% |
Q1 2017 | $377,000 | -12.1% | 6,542 | -6.6% | 0.01% | -20.0% |
Q4 2016 | $429,000 | -12.3% | 7,002 | +98.2% | 0.01% | 0.0% |
Q3 2016 | $489,000 | +19.0% | 3,532 | -4.3% | 0.01% | 0.0% |
Q2 2016 | $411,000 | -80.8% | 3,691 | -79.1% | 0.01% | -80.4% |
Q1 2016 | $2,141,000 | -10.3% | 17,637 | -5.6% | 0.05% | -8.9% |
Q4 2015 | $2,388,000 | -10.7% | 18,691 | -48.5% | 0.06% | +33.3% |
Q3 2015 | $2,673,000 | -43.5% | 36,295 | +4.9% | 0.04% | -55.8% |
Q2 2015 | $4,729,000 | +17.6% | 34,606 | -4.4% | 0.10% | +35.7% |
Q1 2015 | $4,021,000 | +8.0% | 36,188 | -0.3% | 0.07% | +16.7% |
Q4 2014 | $3,724,000 | +39.3% | 36,295 | 0.0% | 0.06% | +42.9% |
Q3 2014 | $2,673,000 | +3.9% | 36,295 | +10.3% | 0.04% | +5.0% |
Q2 2014 | $2,572,000 | +2.5% | 32,914 | -1.2% | 0.04% | -4.8% |
Q1 2014 | $2,509,000 | -0.7% | 33,297 | -0.4% | 0.04% | -2.3% |
Q4 2013 | $2,527,000 | +3.9% | 33,432 | +19.3% | 0.04% | -4.4% |
Q3 2013 | $2,432,000 | +19.9% | 28,027 | 0.0% | 0.04% | +15.4% |
Q2 2013 | $2,029,000 | – | 28,027 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |